Patients with axial psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) plus psoriasis differ with respect to clinical and genetic characteristics, according to the findings of a recent ...
Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. So talking about treatment options in a ...
GRAPPA published treatment recommendations for PsA in 2009 based on evidence from systematic reviews and consensus of 70 rheumatologists and dermatologists with subspecialty expertise in management of ...
MILAN, Italy — Safety considerations, particularly regarding the use of Janus kinase (JAK) inhibitors, are of utmost importance in the 2023 update to recommendations for managing psoriatic arthritis ...
Sustained improvements across stringent measures of disease in patients with psoriatic arthritis (PsA): One-year improvements were sustained to three years across measures of peripheral arthritis, ...
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that causes inflammation, pain, and stiffness in the joints. But RA is a systemic disease — it affects the whole body — and can damage ...
The first set of international treatment guidelines for psoriatic arthritis address the five most significant clinical manifestations of this chronic systemic inflammatory disorder, which afflicts ...
Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. So diagnosis of psoriatic arthritis at this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results